INTERASMA scientific network (INES) is running a internet based survey on "beliefs and behaviours about biological treatments for severe asthma"

Juan Carlos Ivancevich Friday, 31 August 2018 15:37
Dear colleagues, INTERASMA scientific network (INES) is running a  internet based survey on "beliefs and behaviours about biological  treatments for severe asthma" which you can access by clicking on the  following link: http://survey.inesnet.eu/BTSA/accesso.aspx
The survey is anonymous however if you wish to leave your e-mail address you will be part of the communication activities and you will be invited to be part of the INES Network*
 
Fulvio Braido
INTERASMA Secretary General
 
* INESnet (Interasma Scientific nertwork) is a meeting place to get to know each other, to know who does what and where. The purpose is to create an international network, to work together, to offer opportunities. The values which underlie this project are the sharing of efforts, facilities, opportunities, thoughts and ideas with the aim to develop and spread a critical quantity of scientific products, favoring rapidity in full respect of scientific rigor. The drivers for all INESnet members should be to be part of a recognized scientific network and the achievement of benefits from cooperative working. The expected change is the increase of members' scientific expertise (CV- career) and the opportunity to grow from the professional point of you. INESnet was born as an editorial project on obstructive lung diseases. The starting working tool will be a dedicated digital platform for meeting, sharing, discussing, researching and writing papers. This will allow to start a tight collaboration characterized by mindedness, fluency, speed, productivity on a broad field of issues in obstructive lung diseases.
 
-- Fulvio Braido, MD
Associate Professor of Respiratory Medicine
University of Genoa
Respiratory Diseases and Allergy Clinic
Ospedale Policlinico San Martino 
Pad.Maragliano - L.R. Benzi 10 - 16132 - Genova (IT)
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

GAA-INTERASMA Scientific Network

Super User Friday, 31 August 2018 15:07

Invitation

Dear colleagues, GAA-INTERASMA scientific network (INES) is running an internet based survey on “beliefs and behaviours about  biological treatments for severe asthma” which you can access by clicking on the following link:

http://survey.inesnet.eu/BTSA/accesso.aspx

The survey is anonymous however if you wish to leave your e-mail address you will be part of the communication activities and  you will be invited to be part of the INES Network*

Fulvio Braido

GAA-INTERASMA Secretary General

 

INES (GAA-INTERASMA Scientific network)

* INESnet (GAA-INTERASMA Scientific nertwork) is a meeting place for members to get to know each other, to know who does what and where. The purpose is to create an international network, to work together and offer opportunities. The values which underlie this project are the sharing of efforts, facilities, opportunities, thoughts and ideas with the aim to develop and spread a critical quantity of scientific products, favoring rapidity in full respect of scientific rigor. The drivers for all INESnet members should be to be part of a recognized scientific network and the achievement of benefits from cooperative working. The expected change is the increase of members’ scientific expertise (CV- career) and the opportunity to grow from the professional point of view. INESnet was born as an editorial project on obstructive lung diseases. The startingworking tool will be a dedicated digital platform for meeting, sharing, discussing, researching and writing papers. This will allow to start a tight collaboration characterized by open-mindedness, fluency, speed, productivity on a broad field of issues in obstructive lung diseases.

The following new article have just been published in Asthma Research and Practice: Exhaled biomarkers in childhood asthma: old and new approaches

Juan Carlos Ivancevich Wednesday, 08 August 2018 13:06
Review - Open Access
 
Valentina Ferraro, Silvia CarraroSara BozzettoStefania Zanconato and Eugenio Baraldi
 

Abstract

Background

Asthma is a chronic condition usually characterized by underlying inflammation. The study of asthmatic inflammation is of the utmost importance for both diagnostic and monitoring purposes. The gold standard for investigating airway inflammation is bronchoscopy, with bronchoalveolar lavage and bronchial biopsy, but the invasiveness of such procedures limits their use in children. For this reason, in the last decades there has been a growing interest for the development of noninvasive methods.

Main body

In the present review, we describe the most important non-invasive methods for the study of airway inflammation in children, focusing on the measure of the fractional exhaled nitric oxide (feNO), on the measure of the exhaled breath temperature (EBT) and on the analysis of both exhaled breath condensate (EBC) and exhaled air (Volatile Organic Compounds, VOCs), using targeted and untargeted approaches. We summarize what is currently known on the topic of exhaled biomarkers in childhood asthma, with a special emphasis on emerging approaches, underlining the role of exhaled biomarkers in the diagnosis, management and treatment of asthma, and their potential for the development of personalized treatments.

Conclusion

Among non-invasive methods to study asthma, exhaled breath analysis remains one of the most interesting approaches, feNO and “-omic” sciences seem promising for the purpose of characterizing biomarkers of this disease.

Download PDF

 

 

 

The following new articles have just been published in Asthma Research and Practice

Juan Carlos Ivancevich Monday, 23 July 2018 17:00

RESEARCH

Assessment of predictors for acute asthma attack in asthmatic patients visiting an Ethiopian hospital: are the potential factors still a threat?

Asthma Research and Practice 2018, 4:8 | Published on: 16 July 2018
Full Text | PDF

WCA 2018 - Scientific Advisory Board

Juan Carlos Ivancevich Tuesday, 17 July 2018 12:58

Eugenio Baraldi
Francesco Blasi
Jean Bousquet
Andy Bush
Juan Celedon
Adnan Custovic
Gennaro D’Amato
Ronald Dahl
Stephen T. Holgate
Peter Le Souef
Giovanni Passalacqua
Ian Pavord
Ruby Pawankar
Gustavo Rodrigo
Lanny Rosenwasser
Dirceu Sole
James Sublett
Mario Sαnchez-Borges
Johan Christian Virchow

https://wca-2018.com/

Assessment of predictors for acute asthma attack in asthmatic patients visiting an Ethiopian hospital: are the potential factors still a threat?

Juan Carlos Ivancevich Tuesday, 17 July 2018 12:46
Research - Open Access

Sewunet Admasu Belachew Daniel Asfaw ErkuDawit Kumilachew Yimenu and Begashaw Melaku Gebresillassie

Background

Recurrent exacerbations in patients with moderate or severe asthma are the major causes of morbidity, mortality and medical expenditure. Identifying predictors of frequent asthma attack might offer the fertile ground of asthma management. However, systematic data on asthma management is scarce in Ethiopia.

Objective

The purpose of the present study was to determine predictors of acute asthma attack in patients with asthma attending emergency department of University of Gondar Comprehensive Specialized Hospital (UOGCSH) in Gondar, northwestern Ethiopia.

Methods

An institutional-based cross-sectional self-administered survey was conducted on 108 asthmatic patients who came to the emergency department of UOGCSH following acute asthma attack. Data were collected through interviewer administered questionnaire. Logistic regression was done to see the possible association of potential factors that may lead to asthma exacerbation.

Result

About half of the respondents (51.9%) were female and one third of patients (38.9%) were within the age range of between 46 and 60 years. The leading potential predictor were frequent exposure to various ongoing allergen (68.5%) followed by revelation to occupational sensitizers (67.6%). Chronic sinusitis (AOR = 3.532, 95% CL = 1.116–11.178), obstructive sleep apnea (AOR = 3.425, 95% CL = 1.255–9.356) and psychological disfunctioning (3.689 (1.327–10.255)) were among the significantly associated factors of acute asthma exacerbation.

Conclusions

Now days, the backbone for long-term asthma management is to prevent exacerbations. Chronic sinusitis, obstructed sleep apnea and psychosocial dysfunction were originated to be considerably linked with repeated exacerbations of asthma. Among those significantly associated predictors, obstructed sleep apnea were the most prevalent one.

Download PDF

World Congress of Asthma - October 3-6, 2018, Tokyo, Japan / Abstract

Juan Carlos Ivancevich Monday, 11 June 2018 11:41

Dear Sir/Madam,

Following the request from several participants we have the pleasure and honor to inform you that the deadline for submission of abstracts has been extended until June 30, 2018. The early bird fee is therefore also extended until June 30, 2018.

Sincerely,

WCA2018
AMC/Core PCO
 

Online Version

FREI SA
Paparigopoulou 3
Athens 10561
Greece
http://www.frei.gr

 

 

Deadline to submit an abstract for the XXIV World Congress of Asthma in Tokyo, Japan, October 3-6, 2018, expires on Friday, June 8

Juan Carlos Ivancevich Friday, 25 May 2018 16:03


The deadline to electronically submit an abstract for the XXIV World Congress of Asthma in Tokyo, Japan, October 3-6, 2018, expires on Friday, June 8, so you still have the opportunity to take advantage of the Early Bird Registration fee.

To Submit your Abstract please click HERE

To Register please click HERE

 

Your data privacy and communication preferences are a top priority for us so in order to comply with GDPR consent requirements, we need to know that you would still like to receive content in relation to Global Asthma Association - Interasma and its World Congress of Asthma.  

We will only contact you with useful information in relation to and on behalf of the GAA-Interasma Board and the Organizing & Scientific Committees of WCAs.


If you prefer to be opted out of all communications, please click the Unsubscribe link below.


Sincerely,

WCA2018
AMC/Core PCO
Niki Gargassoula

Asthma Research and Practice: Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms

Juan Carlos Ivancevich Tuesday, 22 May 2018 12:40
Ryosuke SoumaKumiya Sugiyama, Hiroyuki MasudaHajime ArifukuKentaro NakanoHiroyoshi WatanabeTomoshige WakayamaShingo TokitaMasamitsu TatewakiHideyuki SatohKenya KoyamaYumeko HayashiFumiya FukushimaHirokuni HirataMasafumi ArimaKazuhiro KurasawaTakeshi Fukuda and Yasutsugu Fukushima

Abstract

Background

The combination of budesonide + formoterol (BFC) offers the advantages of dose adjustment in a single inhaler according to asthma symptoms. We analyzed the relationship between asthma symptoms in terms of peak expiratory flow (PEF) and dose adjustment by the patient.

Methods

Twenty-eight patients with asthma who used BFC for alleviation of their symptoms (12 men, 16 women; 60 years old) were instructed that the inhaled BFC dose could be increased to a maximum of 8 inhalations per day according to symptom severity. Patients measured and recorded PEF every morning and evening in their asthma diary along with their symptoms and the dose of drugs taken.

Results

Sixteen of the 28 patients increased their dose for asthma symptoms. The time to recovery from the asthma symptoms was significantly shorter when cough was the only symptom present compared with dyspnea or wheeze (1.4 vs. 5.3 or 6.6 days, p < 0.05) and when they had only one symptom compared with two or three symptoms (1.3 vs. 5.7 or 10.5, p < 0.01). The relationship between PEF (% of personal best) when the dose was increased (Y) and the days for the increased dose to achieve a PEF greater than PEF in the symptom-free state (X) was determined to be Y = − 0.591X + 89.2 (r2 = 0.299, p < 0.001).

Conclusion

As a guide for increasing the BFC dose when patients with mild asthma have asthma symptoms, the dose should be increased when cough is present or PEF is decreased to 88.9% (i.e., X = 0.5).

Download PDF

XIV World Congress of Asthma: Preliminary Program https://wca-2018.com/scientific-program/

Juan Carlos Ivancevich Monday, 21 May 2018 21:55

XIV World Congress of Asthma:  Preliminary Program

 

https://wca-2018.com/scientific-program/

Interasma on Twitter

Interasma RT @worldallergy: WISC 2018 - Florence Dec. 6-9 Registration online will be closed on November 20th. After this date, registration will on…
17hreplyretweetfavorite
Interasma RT @worldallergy: Top 10 Scientific Articles in the field of psychosocial aspects of allergy published in 2017 (or 2016 as noted). https://…
17hreplyretweetfavorite
Interasma RT @Aller_MD: “#Asthma biologic prices ‘far out of alignment’ with benefit, says ICER” https://t.co/rIKq8LypH9 https://t.co/t8vGuROsUw
17hreplyretweetfavorite
Interasma RT @Aller_MD: “Risk Factors ID'd for Persistent Atopic Dermatitis in Kids Could help clinicians personalize disease prediction” https://t.c…
17hreplyretweetfavorite
Interasma RT @RhinologyO: “The otolaryngologists’ non-surgical training needs to extend beyond the limits of ENT” http…
19hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma